Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
IWR-1-endo: Wnt Signaling Inhibitor Workflows
2026-09-16
IWR-1-endo enables controlled pathway perturbation across colorectal cancer, stem-cell, regeneration, and exploratory cardiac assays. This practical guide links Axin-complex stabilization to reproducible dosing, morphology profiling, β-catenin readouts, and troubleshooting.
-
Meropenem Workflows for Resistance Research
2026-09-16
Build reproducible Meropenem assays for susceptibility testing, resistance dynamics, and Gram-negative infection models. This workflow-centered guide connects PBP biology with plasmid-transmission analysis, formulation comparisons, and septicemia treatment research while keeping exploratory findings separate from clinical interpretation.
-
2,2,2-Trichloroethanol for Protein Analysis
2026-09-15
Use 2,2,2-Trichloroethanol as a flexible protein analysis reagent for electrophoresis, assay development, and molecular biology research. Its water, ethanol, and DMSO solubility supports practical screening, while DAT-imaging research shows why orthogonal protein-level validation matters in translational workflows.
-
Phosbind Acrylamide for Mechanism-Driven Phospho Assays
2026-09-15
Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis by converting phosphate-dependent binding into an SDS-PAGE mobility readout. This article explains how to use the reagent strategically when studying EV71 host-factor biology, while distinguishing protein phosphorylation from PI4P lipid signaling.
-
Annexin A7, TIA1 Trafficking, and Axonal Protection
2026-09-14
The reference study identifies Annexin A7 as a calcium-sensitive regulator that helps couple TIA1-containing ribonucleoprotein granules to cytoplasmic dynein for retrograde axonal transport. Its findings connect impaired RNA granule trafficking with pathological TIA1 aggregation, axonopathy, and neurodegeneration, providing a mechanistic framework for studying how transport failure contributes to disease.
-
Septin4, VHL, and HIF-1α in Cardiac Hypoxia
2026-09-14
The reference study identifies HIF-1α as a previously unrecognized Septin4-interacting protein in hypoxia-stressed cardiomyocytes. Its data indicate that Septin4 strengthens VHL-dependent HIF-1α degradation, reducing a protective hypoxic response and intensifying apoptosis, while also defining experimental considerations for studying oxygen-sensing pathways.
-
Phenothiazines, ROS, and Autophagy in Macrophage Defense
2026-09-13
Qiu and colleagues show that phenothiazines strengthen macrophage antibacterial activity by increasing lysosomal function, autophagy, and reactive oxygen species accumulation. Inhibitor and scavenger experiments, together with an in vivo Salmonella Typhimurium model, support a host-directed mechanism that is especially relevant to intracellular bacterial infections, while leaving compound-specific and translational questions open.
-
SM-102: Reliable LNP Workflows for Cell Assays
2026-09-12
Learn how SM-102 (SKU C1042) can support controlled mRNA delivery experiments and more interpretable cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers solvent compatibility, controls, formulation handling, data interpretation, and practical vendor selection.
-
Ciprofloxacin in Applied Research Workflows
2026-09-11
Ciprofloxacin supports reproducible antibacterial, resistance, and mechanism-focused experiments when solubility, exposure, and controls are managed carefully. This guide also translates a 2026 nanotheranostic study into practical assay choices without overstating the compound’s oncology evidence.
-
Oxaliplatin: DNA Damage and Cancer Models
2026-09-11
Oxaliplatin is a platinum-based chemotherapeutic agent that forms DNA adducts and supports apoptosis induction via DNA damage in cancer research. Its established colorectal cancer use, preclinical combination evidence, formulation constraints, and model-specific limitations make it useful for cancer chemotherapy and resistance studies.
-
Meropenem as a Benchmark for Infection Models
2026-09-10
Meropenem is a β-lactam antibiotic carbapenem with an unusually broad antibacterial profile. This article reframes it as a mechanistic benchmark for designing infection, exposure-response, formulation, and resistance assays rather than as a routine protocol reagent.
-
From Vaccine Signal to Translational IgG Evidence
2026-09-10
Variant-aware vaccine development depends on more than antigen design: it requires assay architectures that translate immune responses into reproducible evidence. This thought-leadership article connects preclinical SARS-CoV-2 vaccine findings with practical human IgG detection using the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody.
-
Thermal-Protective Hydrogel for Tumor Ablation
2026-09-09
The reference study introduces MR@CaP@HA, an injectable hydrogel that combines local thermal insulation with pH- and glutathione-responsive delivery of mitoxantrone and Resiquimod (R-848). By protecting adjacent tissue while promoting immunogenic cell death and innate immune activation, the platform improved residual-tumor control after radiofrequency ablation and provides a material-based strategy for cancer immunotherapy research.
-
JNJ-26854165 (Serdemetan): Assay Guide
2026-09-09
A scenario-driven guide to using JNJ-26854165 (Serdemetan), SKU A4204, in cell viability, proliferation, apoptosis, migration, and radiosensitization studies. It connects HDM2–p53 biology with practical formulation, controls, data interpretation, and vendor-selection decisions.
-
11β-HSD1 Inhibition in Liver Fibrosis
2026-09-09
A 2025 mouse study identifies a mechanistic link between 11β-HSD1 inhibition, reduced intracellular cortisol, Notch pathway suppression, and enhanced natural killer cell activity during liver fibrosis. The findings expand liver fibrosis research beyond stellate-cell signaling alone, while the thioacetamide model and absence of clinical data limit direct translation to human MASLD or MASH.